The Lancet Oncology: July 29, 2009

The Lancet Oncology in conversation with - A podcast by The Lancet Group

Categories:

Education

Rob Brierley discusses sunitinib for kidney cancer, and how bureaucracy is stifling UK clinical research. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv